Selectis Health EBIT per Share
The EBIT per Share of Selectis Health (GBCS) as of Nov 19, 2026 is -0.51 USD. In the previous year, EBIT per Share was -0.89 USD — a change of -42.67% (higher).
Get this data via API
Financial Data API
EBIT per Share
-0.51USD
YoY
-42.67%
Last updated:
The Selectis Health EBIT per Share history
3 Years
10 Years
25 Years
Max
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | 3.67USD | +32.41% |
| est | 2.77USD | +283.90% |
| est | 0.72USD | -241.59% |
| -0.51USD | -42.67% | |
| -0.89USD | -69.54% | |
| -2.92USD | +3,009.63% | |
| -0.09USD | -61.36% | |
| -0.24USD | -119.67% | |
| 1.24USD | +2,387.99% | |
| 0.05USD | +291.77% | |
| 0.01USD | -28.19% | |
| 0.02USD | -866.39% | |
| -0.00USD | -99.62% | |
| -0.60USD | +84.97% | |
| -0.33USD | +41,521.13% | |
| -0.00USD | -95.13% | |
| -0.02USD | -86.61% | |
| -0.12USD | -93.93% | |
| -1.98USD | -669.91% | |
| 0.35USD | -0.18% | |
| 0.35USD | -22.75% | |
| 0.45USD | -50.73% | |
| 0.91USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Selectis Health Stock analysis
Frequently Asked Questions about Selectis Health stock
EBIT per Share of Selectis Health is -0.51 USD in 2025.
EBIT per Share of Selectis Health changed from -0.89 USD to -0.51 USD, representing a -42.67% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Selectis Health since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Selectis Health
All Key Metrics — Selectis Health
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth